Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).
Journal: JCO precision oncology
Published: October 23, 2025
Patient Preferences on Clinical Decision Making in Multiple Myeloma.
Journal: JCO oncology practice
Published: July 24, 2025
Access barriers to hematopoietic stem cell transplantation and CAR T-cells in US.
Journal: Leukemia & lymphoma
Published: July 06, 2025
Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis.
Journal: American journal of cancer research
Published: May 19, 2025
Patterns of relapse in patients with multiple myeloma receiving chimeric antigen receptor T cell therapy: a multi-center analysis.
Journal: Leukemia
Published: March 12, 2025
The past, present, and future of myeloma staging and risk prognostication.
Journal: The oncologist
Published: January 07, 2025
Novel chemotherapy combination of carfilzomib with dexamethasone, cyclophosphamide, etoposide and cisplatin (K-DCEP) for the treatment of relapsed/refractory aggressive plasma cell dyscrasias.
Journal: Leukemia & lymphoma
Published: June 02, 2024
Multiple Myeloma in Young Patients: A Scoping Review.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 26, 2023
Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials.
Journal: Leukemia & lymphoma
Published: May 12, 2023
Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
Journal: British journal of haematology
Published: July 26, 2022
Last Updated: 09/26/2026